Key Record Dates Identifier: NCT02288247
Brief Title: A Study to Assess the Benefit of Treatment Beyond Progression With Enzalutamide in Men Who Are Starting Treatment With Docetaxel After Worsening of Their Prostate Cancer When Taking Enzalutamide Alone (PRESIDE)

First Submitted : November 7, 2014
First Submitted that Met QC Criteria : November 7, 2014
First Posted : November 11, 2014 (Estimate)

Last Update Submitted that Met QC Criteria : June 4, 2019
Last Update Posted : June 5, 2019